Anderson Jeffrey A. 4/A
4/A · REVA Medical, Inc. · Filed Jun 14, 2012
Insider Transaction Report
Form 4/AAmended
REVA Medical, Inc.RVA:AX
Anderson Jeffrey A.
VP, Clinical & Regulatory
Transactions
- Sale
Common Stock
2012-06-05$6.16/sh−2,500$15,400→ 5,000 total - Sale
Common Stock
2012-06-05$6.18/sh−2,500$15,450→ 0 total - Sale
Common Stock
2012-06-05$6.16/sh−2,500$15,400→ 2,500 total
Footnotes (5)
- [F1]Represents the sale of 25,000 of the Company's Chess Depositary Interests (CDIs), trading on the Austrialian Securities Exchange.
- [F2]The purchase was executed in the form of CDIs, trading on the Austrialian Securities Exchange, and as such the purchase price has been converted to a USD equivalent, adjusting for the ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction.
- [F3]The original Form 4 Report filed on June 6, 2012 incorrectly stated the price as $5.88.
- [F4]The original Form 4 Report filed on June 6, 2012 incorrectly stated the price as $5.97.
- [F5]The original Form 4 Report filed on June 6, 2012 incorrectly stated the price as $6.07.